AstraZeneca PLC (LSE: AZN)is a global biopharmaceutical company, researching, developing, manufacturing, and commercialising prescription medicines across oncology, rare disease, cardiovascular, respiratory, and other therapeutic areas.
• GENF shares declined 3.75% on 10 July 2026, closing at 1.93 GBX.• Genflow Biosciences PLC has a market capitalization of approximately 11.33 million GBP, placing it in the micro-cap segment.• The company focuses on longevity biotechnology and developing therapies targeting age-related conditions.• Research …
Investors continue to monitor demand trends within key markets, including China, where pork production economics and disease pressures such as African swine fever have historically influenced demand for genetic products.
• SAR shares gained 3.87% on 10 July 2026, closing at 23.89 GBX.• Sareum Holdings PLC has a market capitalization of approximately 31.87 million GBP, placing it in the micro-cap segment.• The company is a clinical-stage biotechnology business focused on developing therapies for autoimmune …
• EDX shares gained 7.69% on 10 July 2026, closing at 10.50 GBX.• EDX Medical Group PLC has a market capitalization of approximately 40.17 million GBP, placing it in the small-cap segment.• The company develops diagnostic testing solutions and healthcare technologies for disease detection …
Shield Therapeutics Plc (AIM: STX)Shield Therapeutics plc is a commercial-stage specialty pharmaceutical company that develops and markets Feraccru/Accrufer, an oral treatment for iron deficiency, through direct sales and partnering arrangements in various markets.
Poolbeg Pharma PLC (AIM: POLB)Poolbeg Pharma plc is a UK biopharmaceutical company focused on developing treatments for infectious diseases, using a capital-efficient model that advances assets through early clinical development before seeking partnering or licensing opportunities.
Tristel Plc (AIM: TSTL)Tristel plc develops and manufactures infection prevention and decontamination products, based on chlorine dioxide technology, used primarily for high-level disinfection of medical devices in healthcare settings.
• SPI shares gained 0.95% on 9 July 2026, closing at 213.50 GBX.• Spire Healthcare Group PLC has a market capitalization of approximately 851.84 million GBP.• The company operates a network of private hospitals and healthcare facilities providing medical treatments and specialist services.• Healthcare …
• PRTC shares gained 0.51% on 9 July 2026, closing at 118.80 GBX.• PureTech Health PLC has a market capitalization of approximately 287.72 million GBP, placing it in the small-cap healthcare segment.• The company develops biotechnology businesses and advances therapeutic programmes through its research …